Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin Hertlein

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Blood|November 29, 2014
A FOXy target in B-cell survivalErin Hertlein
Blood|June 26, 2010
HLA-DR meets ERKErin Hertlein, John C Byrd
Best Practice & Research. Clinical Haematology|July 13, 2010
Signalling to drug resistance in CLLErin Hertlein, John C Byrd
Blood|April 29, 2008
CLL and activated NF-kappaB: living partnershipErin Hertlein, John C Byrd
Molecular and Cellular Biology|June 1, 2005
RelA/p65 regulation of IkappaBbetaErin Hertlein, Jingxin Wang, Katherine J Ladner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
ASC directs NF-kappaB activation by regulating receptor interacting protein-2 (RIP2) caspase-1 interactionsAnasuya Sarkar, Michelle Duncan, Judy Hart, et al.
Molecular and Cellular Biology|April 18, 2007
NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genesHuating Wang, Erin Hertlein, Nadine Bakkar, et al.
Cell Cycle (Georgetown, Tex.)|November 11, 2009
Epigenetic alterations in a murine model for chronic lymphocytic leukemiaShih-Shih Chen, Mara H Sherman, Erin Hertlein, et al.
Cancer Immunology Research|June 12, 2016
Lenalidomide Induces Interleukin-21 Production by T Cells and Enhances IL21-Mediated Cytotoxicity in Chronic Lymphocytic Leukemia B CellsRebekah L Browning, William H Byrd, Nikhil Gupta, et al.
Leukemia & Lymphoma|January 15, 2016
A phase I trial of the intravenous Hsp90 inhibitor alvespimycin (17-DMAG) in patients with relapsed chronic lymphocytic leukemia/small lymphocytic lymphomaKami Maddocks, Erin Hertlein, Timothy L Chen, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Blood|November 29, 2014
A FOXy target in B-cell survivalErin Hertlein
Blood|June 26, 2010
HLA-DR meets ERKErin Hertlein, John C Byrd
Best Practice & Research. Clinical Haematology|July 13, 2010
Signalling to drug resistance in CLLErin Hertlein, John C Byrd
Blood|April 29, 2008
CLL and activated NF-kappaB: living partnershipErin Hertlein, John C Byrd
Molecular and Cellular Biology|June 1, 2005
RelA/p65 regulation of IkappaBbetaErin Hertlein, Jingxin Wang, Katherine J Ladner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
ASC directs NF-kappaB activation by regulating receptor interacting protein-2 (RIP2) caspase-1 interactionsAnasuya Sarkar, Michelle Duncan, Judy Hart, et al.
Molecular and Cellular Biology|April 18, 2007
NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genesHuating Wang, Erin Hertlein, Nadine Bakkar, et al.
Cell Cycle (Georgetown, Tex.)|November 11, 2009
Epigenetic alterations in a murine model for chronic lymphocytic leukemiaShih-Shih Chen, Mara H Sherman, Erin Hertlein, et al.
Cancer Immunology Research|June 12, 2016
Lenalidomide Induces Interleukin-21 Production by T Cells and Enhances IL21-Mediated Cytotoxicity in Chronic Lymphocytic Leukemia B CellsRebekah L Browning, William H Byrd, Nikhil Gupta, et al.
Leukemia & Lymphoma|January 15, 2016
A phase I trial of the intravenous Hsp90 inhibitor alvespimycin (17-DMAG) in patients with relapsed chronic lymphocytic leukemia/small lymphocytic lymphomaKami Maddocks, Erin Hertlein, Timothy L Chen, et al.
Pageof 5